<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02881307</url>
  </required_header>
  <id_info>
    <org_study_id>Weight Loss Ultrasound RA Proj</org_study_id>
    <nct_id>NCT02881307</nct_id>
  </id_info>
  <brief_title>Ultrasound Assessment of Rheumatoid Arthritis Patients Who Changed Diet</brief_title>
  <official_title>Ultrasound Assessment of Rheumatoid Arthritis Patients Who Changed Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Veena Ranganath</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to evaluate if a weight loss intervention will improve
      your rheumatoid arthritis disease activity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot 12-week RCT (Randomized Clinical Trial) in 60 obese RA (Rheumatoid Arthritis)
      patients to evaluate if a weight loss intervention will improve PDUS (Power Doppler Ultra
      Sound), traditional disease activity measures (DAS28, Disease Activity Score - 28), and
      adipokine/MBDA (Multi-Biomarker Disease Activity) assessments. While there have been
      observational weight loss RA studies, none were RCTs and they did not utilize objective
      measures (PDUS or MBDA).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Controlled Clinical Trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Ultrasonographer and joint assessor are blinded to the diet intervention and to each others assessments.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change in PDUS</measure>
    <time_frame>change from baseline to 6 and 12 months</time_frame>
    <description>Change in Synovitis measure using Ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in DAS28</measure>
    <time_frame>change from baseline to 6 and 12 months</time_frame>
    <description>Change in DAS28 represents conventional measure of reduced disease activity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MBDA</measure>
    <time_frame>Baseline, 6 weeks and 12 weeks</time_frame>
    <description>Biomarker</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Dietary Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary Counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey Protein&amp;Prebiotic Supplement</intervention_name>
    <description>Dietary supplement (protein drink) commercially available protein shakes</description>
    <arm_group_label>Dietary Supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary Counseling</intervention_name>
    <description>Dietary Counseling</description>
    <arm_group_label>Dietary Counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary recommendations</intervention_name>
    <description>recommendations for one meal per day including lean protein and vegetables</description>
    <arm_group_label>Dietary Supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient must meet 1987 ACR (American College of Rheumatology) criteria

          2. Age &gt; 18 years of age

          3. Baseline DAS28/ESR&gt;3.2 (ESR-erythrocyte sedimentation rate)

          4. Stable DMARDs or biologic therapy for at least 12 weeks, or stable off RA therapy 12
             weeks.

          5. Willingness to participate in a weight loss program

          6. BMI &gt; 30

          7. Prednisone â‰¤ 10 mg

          8. Patient has provided informed consent

        Exclusion Criteria:

          1. Major surgery (including joint surgery) within 8 weeks prior to baseline or planned
             major surgery within 3 months after baseline

          2. Evidence of serious uncontrolled concomitant cardiovascular, nervous system,
             pulmonary, renal, hepatic, endocrine, or gastrointestinal disease

          3. Known active current or history of recurrent bacterial, viral, fungal, mycobacterial
             or other infections (as this may falsely elevate biomarkers)

          4. Any major episode of infection requiring hospitalization or treatment with IV
             antibiotics within 4 weeks of baseline or oral antibiotics within 2 weeks prior to
             baseline

          5. Pregnant women or nursing (breast feeding) mothers

          6. Neuropathies or other conditions that might interfere with pain evaluation unless
             related to primary disease under investigation

          7. History of an eating disorder

          8. History of bariatric surgery

          9. EKG results deeming patient to unsafe for study intervention

         10. Allergy to study intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Veena K Ranganath, M.D., M.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Veena K Rangantah, M.D., M.S.</last_name>
    <phone>310-825-3061</phone>
    <email>vranganath@mednet.ucla.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCLA David Geffen School of Medicine, Division of Rheumatology</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Raymond</last_name>
      <phone>310-206-4112</phone>
      <email>jraymond@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Veena K Ranganath, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2016</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Dr. Veena Ranganath</investigator_full_name>
    <investigator_title>Associate Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Rheumatoid Arthritis (RA)</keyword>
  <keyword>Musculoskeletal Ultrasound (MSUS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

